Home
|
Survey
|
Payment
|
Talks & Presentations
|
Job Opportunities
Journals
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
Drug Evaluation
1672-2809
2014 Issue 19
su du
..............
page:6-7
wei ge lie ting zai 2 xing tang niao bing he bing man xing shen zang bing huan zhe zhong de ying yong
guo li xin ;
..............
page:8-11,35
Biphasic insulin-more accord withdietary patterns and insulin function in Chinese patients with type 2 diabetes
gu wei jun ;
..............
page:12-15,26
Weight management effect on healthy and economy inpatients with type 2 diabetes
guan xiao dong ;, han zuo ;, shi lu wen ;, wang tian zuo ;
..............
page:16-19,45
Clinical efficacy and safety of sitagliptin in the treatment of newly diagnosed type 2 diabetes
LIU Pei-wen;,LIU Shuang;,MA Zhi-qiang;,QIU Xue-qin;,WANG Jin-hua;,WANG Xiao-dong;
..............
page:20-22
Treatment strategy of basal insulin onthe basis of national guideline
zhang hong jun ;
..............
page:23-26
SGLT2 inhibitors-latest archetype ofantidiabetic drugs
jia pei ;, li chang qi ;, wang fu yin ;
..............
page:27-29,38
Basal-bolus insulin to premixed insulintherapy in patients with type 2 diabetes
guo qi zuo ;
..............
page:30-32
Detemir and biphasic insulin asparttheatment of diabetes mellitus in pregnancy
zuo jing tao ;, wang ying nan ;
..............
page:33-35
Vildagliptin treatment of type 2diabetes combined with coronary heart disease
shi xiao yun ;, wang li ;
..............
page:36-38
Vildagliptin treatment of elderlypatients with type 2 diabetes
shi xiao yun ;, wang li ;
..............
page:39-40
Efifcacy and safety of vildagliptin, saxagliptin or sitagliptinas add-on therapy in Asian patients with type 2 diabetes
..............
page:41-45
2014 zhong guo tang niao bing zu ji xiang guan ji bing lun tan ji yao
ran xing wu ;, wang chun ;, xu zhang rong ;
..............
page:46-48